辅助生殖技术中血HCG值与妊娠结局相关因素分析  

Analysis of factors related to blood HCG and pregnancy outcome in assisted reproductive technology

作　　者：陈嫦娥[1] Chen chang’e(First Affiliated Hospital of Anhui Medical University Obstetrics and Gynecology Reproductive Medicine Center Anhui,Hefei 23002)

机构地区：[1]安徽医科大学第一附属医院妇产科生殖医学中心,安徽合肥230022

出　　处：《医学食疗与健康》2018年第5期15-16,共2页Medical Diet and Health

摘　　要：目的：本文将对辅助生殖技术中血HCG值与妊娠结局相关因素进行分析,探讨辅助生殖技术对不孕患者治疗后,β绒毛膜促性腺激素（β-HCG）值单次以及动态预测妊娠结局的意义,从而确保临床治疗疗效.方法：将我院2016年1月-2016年3月接收的146例不孕患者作为此次实验研究对象,患者均接受辅助生殖技术,监测排卵后16d的血β-HCG值以及上升状态,探究对妊娠结局的影响,根据妊娠期限,是否超过12周对患者进行分组,为继续妊娠组与不良妊娠组.结果：继续妊娠组123例,血β-HCG值为76.6-2899IU/L,平均（794.6±182.7）IU/L;不良妊娠组23例,血β-HCG值为52.1-427.38IU/L,平均（182.3±46.3）IU/L;助孕措施继续妊娠患者血β-HCG值明显高于不良妊娠患者;对比两组患者血β-HCG值上升情况分布的不同区段,可以观察到继续妊娠患者血β-HCG值上升情况超过100%的占比例为82.4%,而不良妊娠患者仅仅占比例55.2%,血β-HCG值下降患者占12.5%.结论：在辅助生殖技术中,测定血β-HCG值是预测妊娠结局的重要指标.Objective： to investigate the significance of the single value of beta-chorionic gonadotropin（尾-HCG） and the dynamic prediction of pregnancy outcomes after assisted reproduction in infertile patients.Methods： all patients received assisted reproductive technology to monitor he serum -HCG level and the rising state of 16d after ovulation.Results： Comparing the different sections of the distribution of the blood beta-HCG ncrease in the two groups of patients, it can be observed that the proportion of the blood beta-HCG increase in patients with continuous pregnancy exceeding 100 % is 82.4 %, while the proportion of patients with adverse pregnancy is only 55.2 %. Patients with a decrease in blood 尾-HCG accounted for 12.5 %.

关 键 词：辅助生殖技术 血Β-HCG值 妊娠结 

分 类 号：R71[医药卫生—妇产科学]